Cancer research at BESSY II: Binding Mechanisms of Therapeutic Substances Deciphered

The study is displayed on the cover of the journal Chemmedchem.

The study is displayed on the cover of the journal Chemmedchem. © Chemmedchem/VCH Wiley

In tumor cells, the DNA is altered in comparison to normal body cells. How such changes can be prevented or inhibited is an exciting field of research with great relevance for the development of cancer treatments. An interdisciplinary team has now analysed the possible binding mechanisms in certain therapeutic substances from the tetrazole hydrazide group using protein crystallography at BESSY II.

Certain proteins such as human histone demethylases, including the KDM4 protein, play a role in the development of tumour cells. They bind to the DNA and modify it so that the cell can become cancerous. Therapeutic substances that are able to inhibit or even reverse such changes are of particular interest.

Biochemist Prof. Dr. Udo Heinemann from the Max Delbrück Centre in Berlin-Buch is investigating such processes. In cooperation with chemists led by Prof. Dr. Andreas Link from the University of Greifswald and the team led by Dr. Manfred Weiss at the HZB, he has now investigated how and where certain therapeutic substances from the tetrazole hydrazide group dock to these protein molecules and thus inhibit their harmful effect.

KDM4 protein crystals analysed

Link initially produced variations of tetrazole hydrazide substances. For structural analysis, crystals had to be grown from KDM4 proteins - a difficult task that Dr. Piotr Malecki and Manfred Weiss had taken on at the HZB. The KDM4 protein crystals were then soaked in a specific substance before being analyzed with strong X-rays on the MX beamlines of BESSY II. A refined analysis showed not only the three-dimensional architecture of the KDM4 protein, but also exactly where the active substances had docked to the KDM4 molecule.

"This class of substances has not yet been structurally investigated," explains Manfred Weiss.  And Udo Heinemann from the MDC explains: "We will now evaluate where there are opportunities to dock even stronger within the 3D structure of the KDM4. Then we might also be able to develop drugs that inhibit the KDM4 even more and thus have the potential to become a therapeutic."

arö

  • Copy link

You might also be interested in

  • Bright prospects for tin perovskite solar cells
    Science Highlight
    03.12.2025
    Bright prospects for tin perovskite solar cells
    Perovskite solar cells are widely regarded as the next generation photovoltaic technology. However, they are not yet stable enough in the long term for widespread commercial use. One reason for this is migrating ions, which cause degradation of the semiconducting material over time. A team from HZB and the University of Potsdam has now investigated the ion density in four different, widely used perovskite compounds and discovered significant differences. Tin perovskite semiconductors produced with an alternative solvent had a particular low ion density — only one tenth that of lead perovskite semiconductors. This suggests that tin-based perovskites could be used to make solar cells that are not only really environmentally friendly but also very stable.

  • Synchrotron radiation sources: toolboxes for quantum technologies
    Science Highlight
    01.12.2025
    Synchrotron radiation sources: toolboxes for quantum technologies
    Synchrotron radiation sources generate highly brilliant light pulses, ranging from infrared to hard X-rays, which can be used to gain deep insights into complex materials. An international team has now published an overview on synchrotron methods for the further development of quantum materials and technologies in the journal Advanced Functional Materials: Using concrete examples, they show how these unique tools can help to unlock the potential of quantum technologies such as quantum computing, overcome production barriers and pave the way for future breakthroughs.
  • How carbonates influence CO2-to-fuel conversion
    Science Highlight
    25.11.2025
    How carbonates influence CO2-to-fuel conversion
    Researchers from the Helmholtz Zentrum Berlin (HZB) and the Fritz Haber Institute of the Max Planck Society (FHI) have uncovered how carbonate molecules affect the conversion of CO2 into valuable fuels on gold electrocatalysts. Their findings reveal key molecular mechanisms in CO2 electrocatalysis and hydrogen evolution, pointing to new strategies for improving energy efficiency and reaction selectivity.